Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells

Journal of Virology

Volumn 75, Issue 16, 2001, Pages 7621-7628

  Lisziewicz, J ^a   Gabrilovich, D I ^a   Varga, G ^a   Xu, J ^a   Greenberg, P D ^a   Arya, S K ^a   Bosch, M ^a   Behr, J ^a   Lori, F ^a  

^a Research Institute for Genetic Human Therapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; PLASMID DNA; POLYETHYLENEIMINE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DNA MODIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; MACACA; NONHUMAN; PRIORITY JOURNAL; VIRUS INDUCTION; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; CELL COMMUNICATION; DENDRITIC CELLS; GENETIC VECTORS; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; PLASMIDS; T-LYMPHOCYTES;

EID: 0034909893     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.16.7621-7628.2001     Document Type: Article

References (48)

1. Serial in vivo passage of HIV-1 infection in Macaca nemestrina
2. Dendritic cells and the control of immunity
3. + cytolytic T lymphocytes by dendritic cells
4. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
5. HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA
6. Self-limiting, cell-type dependent replication of an integrase defective HIV-1 in human macrophages but not in human T-lymphocytes
7. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
8. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
9. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus env and Nef
10. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells
11. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells
12. Modelling T-cell memory by genetic marking of memory T cells in vivo
13. + T cell depletion in simian immunodeficiency virus-infected macaques
14. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
15. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
16. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
17. Dendritic cells as targets for cytotoxic T lymphocytes
18. Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation
19. Fibroblasts as efficient antigen-presenting cells in lymphoid organs
20. An electron microscopy study into the mechanism of gene transfer with lipopolyamines
21. Control of HIV despite the discontinuation of antiretroviral therapy
22. Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence
23. Control of SIV rebound through structured treatment interruptions during early infection
24. Dendritic cells efficiently induce protective antiviral immunity
25. + T-cells
26. Antigen processing for amateurs and professionals
27. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins
28. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
29. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
30. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy
31. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
32. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells
33. + T cells after gene gun immunization
34. AIDS vaccine trials in chimpanzees
35. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
36. Immune control of HIV-1 after early treatment of acute infection
37. The role of cytotoxic T-cells in HIV infection
38. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
39. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
40. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
41. + lymphocytes
42. The dendritic cell system and its role in immunogenicity
43. Dendritic cells in the T-cell areas of lymphoid organs
44. HIV-1 replication is controlled at the level of T cell activation and proviral integration
45. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein
46. Direct visualization of HIV-1 specific cytotoxic T lymphocytes during primary infection
47. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
48. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity